Genmab A/S (GMAB) — Capital Reinvestment Ratio
Genmab A/S (GMAB) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow (Dkr536.00 Million) in capital expenditures (Dkr2.00 Million). Check tangible equity quality of Genmab A/S to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genmab A/S Capital Reinvestment Ratio (2007–2024)
This chart tracks Genmab A/S's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see Genmab A/S cash conversion from operations.
Annual Capital Reinvestment Ratio for Genmab A/S (2007–2024)
Year-by-year Capital Reinvestment Ratio for Genmab A/S from 2007 to 2024. See free cash flow generation of Genmab A/S to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | Dkr7.77 Billion | Dkr187.00 Million | ▼ -52.8% |
| 2023 | 0.05x | Dkr7.38 Billion | Dkr376.00 Million | ▼ -37.1% |
| 2022 | 0.08x | Dkr3.91 Billion | Dkr317.00 Million | ▼ -28.4% |
| 2021 | 0.11x | Dkr2.23 Billion | Dkr252.00 Million | ▲ +137.0% |
| 2020 | 0.05x | Dkr6.43 Billion | Dkr307.00 Million | ▼ -43.0% |
| 2019 | 0.08x | Dkr1.33 Billion | Dkr111.00 Million | ▼ -82.2% |
| 2018 | 0.47x | Dkr1.01 Billion | Dkr477.37 Million | ▲ +744.5% |
| 2017 | 0.06x | Dkr1.59 Billion | Dkr88.51 Million | ▼ -44.9% |
| 2016 | 0.10x | Dkr327.72 Million | Dkr33.11 Million | ▼ -76.8% |
| 2015 | 0.43x | Dkr311.45 Million | Dkr135.39 Million | ▼ -23.6% |
| 2014 | 0.57x | Dkr132.67 Million | Dkr75.44 Million | ▲ +348.2% |
| 2012 | 0.13x | Dkr70.92 Million | Dkr9.00 Million | ▲ +236.5% |
| 2010 | 0.04x | Dkr268.17 Million | Dkr10.11 Million | ▲ +48.5% |
| 2007 | 0.03x | Dkr505.90 Million | Dkr12.84 Million | — |